InsiderTrades

Form 4 for MGNX MACROGENICS INC

Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-15 · accession 0001125345-25-000033 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-19 2025-02-15 MGNX Peters Jeffrey Stuart GC, Senior VP F - Tax $2.56 -5,147 13.7K -27% -$13.2K
D 2025-02-19 2025-02-15 MGNX Peters Jeffrey Stuart GC, Senior VP M - OptEx $0.00 +13.3K 18.9K +241% $0
D 2025-02-19 2025-02-15 MGNX Peters Jeffrey Stuart GC, Senior VP M - OptEx $0.00 -13.3K 13.3K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-15 F D 5,147 $2.56 13,711 D — —
2 Common Common Stock 2025-02-15 M A 13,332 $0.00 18,858 D — — (F1) On February 15, 2023, the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
3 Derivative Restricted Stock Unit 2025-02-15 M D 13,332 $0.00 13,332 D $0.00 · — to — 13,332 Common Stock (F1) On February 15, 2023, the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.